News

TheracosBio Partners with PBA Health to Enhance Diabetes Care

TheracosBio Partners with PBA Health to Enhance Diabetes Care

Collaboration for Diabetes Treatment Access

TheracosBio is excited to announce a pivotal partnership with PBA Health, focusing on improving access to diabetes treatment through affordable medication options. The newly available medication, BRENZAVVY (bexagliflozin), is an FDA-approved oral medication specifically designed for individuals with type 2 diabetes. The collaboration with PBA Health marks a significant opportunity for thousands of independent community pharmacies to stock this essential medication.

Understanding BRENZAVVY in Diabetes Management

BRENZAVVY is an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor that has shown effectiveness in treating type 2 diabetes. With its introduction to the pharmacies supported by PBA Health, patients can gain access to an affordable alternative to other medications in the SGLT2 class. This cooperation aims to alleviate the financial burden often associated with diabetes treatment, thereby promoting better health outcomes for patients.

Importance of Independent Community Pharmacies

Independent community pharmacies play an invaluable role in the healthcare system. They are recognized for their personalized care and commitment to serving local communities. The introduction of BRENZAVVY through PBA Health enhances the ability of these pharmacies to provide essential medications to patients who may struggle to afford them. As president and CEO of TheracosBio, Brian Connelly expressed enthusiasm for this initiative, noting the importance of supporting pharmacists in managing their patients' diabetes effectively.

Cost Benefits for Patients

One of the notable advantages of BRENZAVVY is its affordability. Designed with cost in mind, the medication can be obtained for significantly less than many comparable diabetes medications — in fact, it can be up to 90% less expensive for a month’s supply. For individuals on a fixed income, this price reduction can be a game-changer, allowing them to manage their treatment more effectively without compromising their financial stability.

How to Take BRENZAVVY

BRENZAVVY is administered as a 20 mg oral tablet, recommended to be taken once daily. Patients have the flexibility to take it with or without food, making it convenient to incorporate into their daily routine. This accessibility is essential for those managing a chronic condition like diabetes, as adherence to medication is vital for effective treatment.

Clinical Evidence Supporting Efficacy

Clinical trials have demonstrated that BRENZAVVY effectively reduces hemoglobin A1c and fasting blood sugar levels within 24 weeks of treatment. This can occur whether the medication is used alone or in conjunction with other treatments, such as metformin. While it is not approved for weight loss or blood pressure reduction, some patients have reported modest decreases in both, underscoring the medication’s overall benefits.

Commitment to Patient Safety

Patient safety is always a top priority when introducing new medications. BRENZAVVY comes with specific contraindications; it is not recommended for individuals with type 1 diabetes or those who are hypersensitive to any component of the medication. Common side effects include urinary and genital infections, but additional serious side effects can occur, which leads TheracosBio to prioritize thorough testing and monitoring for all patients.

Staying Informed About Potential Risks

Healthcare providers will counsel patients on the risks associated with BRENZAVVY, including diabetic ketoacidosis and urinary tract infections. Adjustments may need to be made for individuals taking insulin or other medications that affect blood sugar levels. Education for both patients and healthcare professionals is crucial to mitigate these risks effectively.

About TheracosBio and PBA Health

Established in 2004, TheracosBio aims to provide novel therapeutics at affordable prices, making healthcare accessible. PBA Health has been a respected leader in pharmacy supply chain solutions since 1983, supporting independent community pharmacies in delivering the best care to their patients.

With this partnership, TheracosBio and PBA Health are set to pave the way for better diabetes management, making a significant difference in the lives of patients across the country.

Frequently Asked Questions

What is BRENZAVVY?

BRENZAVVY is an FDA-approved oral medication used to treat type 2 diabetes, specifically designed to help manage blood sugar levels.

How can I access BRENZAVVY?

BRENZAVVY will be available at participating independent community pharmacies that are part of PBA Health's network.

Why is this partnership significant?

This partnership allows for greater access to affordable diabetes medication for patients who may struggle to afford existing treatments.

What are the common side effects of BRENZAVVY?

Common side effects include urinary tract infections and genital infections. Patients should discuss any concerns with their healthcare provider.

How does BRENZAVVY compare cost-wise to other diabetes medications?

BRENZAVVY can be obtained for up to 90% less than many existing SGLT2 medications, providing a cost-effective option for patients.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

HKEX Unveils New Offshore RMB Bond Index

Updated Category News Views 111

Here's the scoop: Hong Kong Exchanges and Clearing Limited (HKEX) just rolled out something worth eyeing—the HKEX Offshore RMB Bond Index. It's the first of its kind from HKEX, catered to those Dim Sum bonds floating around in the city. With Bloomberg lending a hand on the index smarts, this step is poised to give Hong Kong a leg up in the global financial marathon....

Continue Reading
Mercari and Suruga-ya Forge U.S. Venture for Culture

Updated Category News Views 36

Japanese Pop Culture Gears Up for US Market Surge Alright, folks, what we’ve got here is another bold move in the cross-border e-commerce game. Mercari and Suruga-ya are teaming up to establish a joint venture over in the U.S. The goal? To further capitalize on the growing appetite for Japanese entertainment and hobby goods among us all stateside. Now, it’s no secret...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 358

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 72

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
ELEGRP Makes Dyson Supersonic Global Voltage Ready

Updated Category News Views 26

Plugging Into the Future of Travel ELEGRP's latest move brings the Dyson Supersonic Travel hair dryer into the limelight, all decked out with global voltage compatibility. It's like the Swiss Army knife of hair dryers—one minute it’s working on 100V, next it’s flipping over to a juicy 240V, without breaking a sweat. The ALCI Difference: Safety Takes Center Stage...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 288

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 438

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 395

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 343

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 343

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
rshangout.com/blog/news?page=2">More News Articles